US$ 22.89
glp 1 heart attack GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential Vascular and metabolic effects of
Description
The many alternatives now enable healthcare practitioners to customise the formulation and delivery method according to specific patient preferences and requirements

Efficacy The DURATION-1 study compared exenatide once weekly with exenatide twice daily in patients with uncontrolled T2D being treated with either diet, one or two oral therapies [Drucker et al

doi:10.1007/s13679-021-00444-y Share Table of Contents The Obesity Epidemic Pens vs

Patients with T1D are equally affected by the obesity epidemic, and they have experienced a rapid increase in the prevalence of obesity in the last few years (36)
